DrugPatentWatch Database Preview
Ardelyx Inc Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for ARDELYX INC, and what generic alternatives to ARDELYX INC drugs are available?
ARDELYX INC has one approved drug.
There are four US patents protecting ARDELYX INC drugs.
There are twenty-eight patent family members on ARDELYX INC drugs in twenty-one countries.
Summary for Ardelyx Inc
| International Patents: | 28 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Ardelyx Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ardelyx Inc | IBSRELA | tenapanor hydrochloride | TABLET;ORAL | 211801-001 | Sep 12, 2019 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Ardelyx Inc | IBSRELA | tenapanor hydrochloride | TABLET;ORAL | 211801-001 | Sep 12, 2019 | RX | Yes | Yes | 8,541,448 | Start Trial | Y | Y | Start Trial | ||
| Ardelyx Inc | IBSRELA | tenapanor hydrochloride | TABLET;ORAL | 211801-001 | Sep 12, 2019 | RX | Yes | Yes | 9,408,840 | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Ardelyx Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Israel | 250641 | Start Trial |
| European Patent Office | 2384318 | Start Trial |
| Hungary | E036405 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
